■ INTRODUCTION
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental pollutants and suspect human carcinogens. 1 PAHs are products of incomplete combustion and are emitted into the air we breathe, they are also present in first-hand and second hand smoke, and many are lung tumorigens in experimental animals. 2 PAHs themselves are biologically inert, and their carcinogenic effects require metabolic activation to biologically reactive intermediates, which covalently modify deoxyribonucleic acid (DNA), to form DNA adducts that result in mutation. 3 Three pathways of metabolic activation of benzo [a] pyrene (B[a]P), a representative PAH, have been proposed as the formation of radical cations, 4 the formation of anti-diol-epoxides, 5−7 and the formation of ortho-quinones. 8, 9 In the third pathway, benzo [a] pyrene-7,8-dione (B [a] P-7,8-dione), is produced by the oxidation of (±)-B[a]P-7,8-transdihydrodiol, which is catalyzed by aldo-keto reductases (AKRs). 8, 9 B[a]P-7,8-dione is both electrophilic and redoxactive. The electrophilic B [a] P-7,8-dione can undergo 1,4-or 1,6-Michael addition with glutathione (GSH), and N-acetyl-Lcysteine (NAC) in vitro. 10 It can also react with deoxyguanosine and deoxyadenosine to form a hydrated N 2 -deoxyguanosine adduct, a hydrated cyclic N 2 -deoxyguanosine adduct, a hydrated cyclic N 6 -deoxyadenosine adduct, or a N7-guanine depurinating adduct in vitro (Figure 1 ).
11−14 B[a]P-7,8-dione can also be enzymatically and nonenzymatically reduced back to the catechol and can establish futile redox cycles that result in the amplification of reactive oxygen species (ROS) until cellular reducing equivalents (e.g., NADPH) are depleted. 15, 16 ROS formation can give rise to the mutagenic lesion 8-oxo-2′-deoxyguanosine (8-oxo-dGuo) in A549 and H358 cells ( Figure  1) . 17, 18 Both the N7-guanine depurinating adduct and 8-oxodGuo can give rise to G to T transversions, which are the dominant mutations found in K-ras and p53 in lung cancer.
Human lung cells are major sites of inhalation exposure to B [a] P, and generation of the reactive metabolite B [a] P-7,8-dione from B [a] P has been previously demonstrated in H358 cells. 19, 20 The downstream metabolism of B [a] P-7,8-dione in human lung cells has also been reported. 21 However, to our knowledge, information relevant to the formation of stable B [a] P-7,8-dione-DNA adducts in any human cell line is lacking. The objective of this study was to identify the stable B [a] P-7,8-dione-DNA adducts in human lung cells. A549 (human lung adenocarcinoma cells), H358 (human bronchoalveolar cells), and HBEC-KT (immortalized human bronchial epithelial cells) were selected as three human lung cell lines to investigate the comparative profiles of stable B [a] P-7,8-dione-DNA adducts.
We found that several stable B [a] P-7,8-dione-DNA adducts could be detected in A549 and HBEC-KT cells. In each case, adduct structures were characterized by MS n spectra. We found that A549 cells produced predominately 2′-deoxyguanosine (dGuo) adducts, and HBEC-KT cells produced predominately 2′-deoxyadenosine (dAde) adducts. Adduct structures were also compared to those synthesized from reactions of B[a]P-7,8-dione with dGuo, dAde and salmon testis DNA in vitro but were found to be different.
■ MATERIALS AND METHODS
Caution: All PAHs are potentially hazardous and should be handled in accordance with the NIH Guidelines for the Laboratory Use of Chemical Carcinogens.
Chemicals and Reagents. Cell culture medium and reagents were all obtained from Invitrogen Co. (Carlsbad, CA) except for fetal bovine serum (FBS) which was purchased from Hyclone (Logan, UT). B[a]P-7,8-Dione was synthesized according to published methods.
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2′-Deoxyguanosine (dGuo), 2′-deoxyadenosine (dAde), salmon testis DNA, DNase, nuclease P1, and shrimp alkaline phosphatase (SAP) were purchased from Sigma-Aldrich Co. (St. Louis, MO). All other chemicals used were of the highest grade available, and all solvents were HPLC grade.
Cell Culture. A549 (human lung adenocarcinoma) cells were obtained from American Type Culture Collection (ATCC #CCL-185) and maintained in F-12K nutrient mixture (Kaighn's modification) with 10% heat-inactivated FBS, 2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin. H358 (human bronchoalveolar) cells were obtained from the American Type Culture Collection (ATCC #CRL-5807) and maintained in RPMI 1640 nutrient mixture with 10% heat-inactivated FBS, 2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin. HBEC-KT (immortalized human bronchial epithelial) cells originated from a patient without lung cancer were a gift from Dr. John Minna at University of Texas Southwestern Medical Center and maintained in keratinocyte serum free medium with 0.1−0.2 ng/mL recombinant epidermal growth factor (rEGF), 20−30 μg/mL bovine pituitary extract (BPE), and 2 mM L-glutamine. Cells were incubated at 37°C in a humidified atmosphere containing 5% CO 2 and were passaged every 3 days at a 1:6 dilution. Cultured cells with a passage number of 10−20 were used in the experiments to reduce variability due to cell culture conditions.
Identification of DNA Adducts of B[a]P-7,8-dione in Human Lung Cells. The cells (∼5 × 10 6 ) were treated with B[a]P-7,8-dione (2 μM, 0.2% DMSO) in HBSS buffer containing 1 mM sodium pyruvate as an energy source. The cell pellets were collected by scraping at 0 and 24 h. The DNA from the cell pellets was extracted with a Wako DNA extraction kit (Wako Chemicals USA, Inc., Richmond, VA) and was subsequently dissolved in 300 μL of 20 mM phosphate buffer at pH 7.0.
The solution containing cellular DNA (300 μL) was subjected to enzyme hydrolysis. Thirty microliters of 0.1 M MgCl 2 and 400 units of DNase was added, followed by 1 h of incubation at 37°C. A 5 μL solution containing 50 mM NaOAc and 5 mM ZnCl 2 , pH 5.0, was then added along with 7.5 units of nuclease P1. The sample was incubated for 1.5 h at 37°C. At the end of the incubation, 40 μL of 0.5 M Tris-HCl and 50 mM MgCl 2 , pH 8.5, was added along with 20 units of shrimp alkaline phosphatase (SAP), and the sample was incubated for 1.5 h at 37°C. Ethanol (900 μL) was added to the digestion solution, and the sample was chilled at 0°C for 10 min. The sample solution was centrifuged at 14000 rpm for 10 min at 4°C. The supernatant was transferred to another tube and evaporated under vacuum. The residue was redissolved in 100 μL methanol plus H 2 O (1:1) and analyzed by the ion trap LC-MS/MS. The injection volume was 20 μL. At the end of digestion, RP-HPLC showed that the digestion was complete since only the four deoxyribonucleosides were detected.
Data were acquired using a Waters Alliance 2690 HPLC system (Waters Corporation) coupled to a Finnigan LTQ spectrometer (Thermo Fisher Scientific, San Jose, CA). Separations were accomplished on a reverse-phase (RP) column (Zorbax-ODS C18, 5 μm, 4.6 mm × 250 mm) (DuPont Co., Wilmington, DE) with a guard column at ambient temperature. The mobile phase consisted of 5 mM ammonium acetate and 0.02% formic acid (v/v) in H 2 O (solvent A) and acetonitrile (solvent B) and was delivered at a flow rate of 0.5 mL/ min. The linear gradient elution program was as follows: 20% to 80% B over 40 min, 80% to 95% B over 1 min, followed by an isocratic hold at 95% B for another 4 min. At 45 min, B was returned to 20% in 1 min, and the column was equilibrated for 14 min before the next injection. The total run time for each analysis was 60 min. During LC-MS/MS analysis, up to 6 min of the initial flow was diverted away from the mass spectrometer before the evaluation of eluants. The mass spectrometer was operated in the positive ion mode with an electrospray ionization (ESI) source. Eluants were monitored on the LTQ using product ion scan (MS 2 The DNA pellet was precipitated from the aqueous layer and was subsequently hydrolyzed by stepwise addition of DNase, nuclease P1, and SAP. Ethanol was added to the digestion solution, and the supernatant was dried and subjected to the analysis by ion trap LC-MS/MS. The identity of the DNA adducts of B[a]P-7,8-dione were validated using pseudo-selected reaction monitoring (SRM), MS 2 , and subsequent MS 3 modes in the same manner as that described above. At the end of digestion, RP-HPLC showed that the digestion was complete since only the four deoxyribonucleosides were detected.
■ RESULTS
Strategy. A549, H358, and HBEC-KT cells were treated with 2 μM B[a]P-7,8-dione to detect and identify the potential DNA adducts using ion trap LC-MS/MS. Previous disposition studies with radiolabeled 1,3-
-dione in these three cell lines indicated that there was incorporation of radioactivity into the cell pellet that reached a plateau at 6 h and then stayed constant for up to 24 h. Subfractionation of the cell pellet indicated that the radioactivity was in the protein and DNA fractions with the largest portion being covalently bound to protein. 21 Thus, in our studies we elected to detect covalent DNA adducts following a 24 h treatment with B[a]P-7,8-dione.
The structures of the potential DNA adducts were compared to authentic synthesized standards obtained by reacting B[a]P-7,8-dione with either deoxyribonucleosides as described by Balu, N. et al. 13 or salmon testis DNA. The common fragmentation patterns of dGuo, dAde, and B[a]P-7,8-dione have been reported previously 19,23−26 and are shown in Figure  2 positions of dAde to yield three possible adducts, but addition by the N 6 -exocyclic amino group was expected. Although covalent binding at the N7 positions of dGuo and dAde is also possible, these reactions would give rise to unstable depurinating adducts due to the cleavage of the N-glycosidic bond. On the basis of these known fragmentation patterns, the MS n spectra of potential DNA adducts can be interpreted to obtain more structural information as to their identity. Figure 3A ) and 24 h ( Figure 3B ). The corresponding MS 2 spectra (m/z 566) of these two adducts showed the loss of deoxyribose from the hydrated molecular ion ( Figure 3C ). The MS 3 spectra (m/z 566→450→) of the adduct with a retention time of 11.40 min ( Figure 3D ) and the adduct with a retention time of 13.85 min ( Figure 3E ) showed reasonable fragmentation patterns from both the guanine nucleobase and B[a]P-7,8-dione (loss of CO). In particular, the loss of HNCO (43 amu) in Figure 3D and NH 3 (17 amu) in Figure 3E are characteristic of the fragmentation of the guanine ring. 24 For the adduct with a retention time of 11.40 min, the loss of HNCO (43 amu) shown in Figure 3D strongly indicates that the covalent binding did not occur at the N1 position of dGuo. Covalent binding at the N3 position of dGuo could also be ruled out since the loss of NH 3 (17 amu) was not observed. Thus, Michael addition followed by hydration could account for the formation of the hydrated-B[a]P-7,8-dione-N 2 -dGuo adduct with a retention time of 11.40 min as expected. For the adduct with a retention time of 13.85 min, the loss of NH 3 (17 amu) shown in Figure  3E strongly indicates that the covalent binding did not occur at the N 2 exocyclic amino group of dGuo. Covalent binding at the N3 position of dGuo could also be ruled out since the loss of HNCO (43 amu) was not observed in Figure 3E . Thus, Michael addition by the enol-imidazole tautomer of guanine followed by hydration could account for the formation of the hydrated-B[a]P-7,8-dione-N1-dGuo adduct with a retention time of 13.85 min. The specific position by which guanine Figure 4A ) and 24 h ( Figure 4B ). The corresponding MS 2 spectra (m/z 550) of these two adducts showed the loss of deoxyribose from the hydrated molecular ion ( Figure 4C ). The MS 3 spectra (m/z 550→435→) of the adduct with a retention time of 9.54 min ( Figure 4D ) and the adduct with a retention time of 11.98 min ( Figure 4E ) showed reasonable fragmentation patterns from the adenine nucleobase and B[a]P-7,8-dione (loss of CO). In particular, the loss of NH 3 (17 amu) in Figure  4E is characteristic of the fragmentation of the adenine ring. 24 The loss of NH 3 (17 amu) shown in Figure 4E Figure 5C ) showed reasonable fragmentation patterns from both B[a]P-7,8-dione (loss of CO) and adenine. In particular, the loss of NH 3 (17 amu) and HCN (27 amu) in Figure 5C is characteristic of the fragmentation of the adenine ring. 24 The loss of NH 3 (17 amu) shown in Figure 5C Table 1 ). The structures of these adducts were previously confirmed by nuclear magnetic resonance (NMR) 13 and are shown in Figure S -1A (Supporting Information). However, these adducts were different from stable B[a]P-7,8-dione-dGuo adducts detected in A549 cells based on the retention times (Table 1) .
B [a] P-7,8-Dione was also reacted with dAde under conditions similar to those previously published, 13 and one peak with a retention time of 18.69 min was observed corresponding to the mass transition of a protonated hydrated-B[a]P-7,8-dione-dAde (m/z 550) undergoing the loss of deoxyribose ( Figure S-1B, Supporting Information) . Comparison of the fragmentation patterns of this peak with the corresponding hydrated-B[a]P-7,8-dione-dAde adducts reported previously 13 showed a good concordance ( Table 1 ). The structure of this adduct was previously confirmed by NMR 13 and is shown in Figure S- 27 This is the first report of the ability of B[a]P-7,8-dione to form in vitro stable DNA adducts in human lung cells.
The covalent binding of electrophilic B [a] P metabolites (e.g., anti-diol-epoxides or radical cations) to DNA has been found to be a key step in the initiation of cancer. 2, 5, 15 Formation of dGuo adducts or depurinating adducts from these respective metabolites can lead to G to T transversions.
11−14 Formation of stable B[a]P-7,8-dione-DNA adducts leads to a loss of electrophilicity, but the adducts are still capable of redox-cycling to produce oxidative stress and oxidative DNA damage. Identification of the stable B[a]P-7,8-dione-DNA adducts in human lung cells will allow their mutagenicity to be assessed in lesion bypass assays using site-specifically modified oligonucleotides.
After treatment of A549, H358, and HBEC-KT cells with radiolabeled 1,3-[ 3 H 2 ]-B[a]P-7,8-dione, it was found that a small amount of radioactivity was distributed in the DNA extracted from all cell pellets (data not shown), which is consistent with the previous finding of radioactivity disposition in isolated rat hepatocytes. 28 Among the three human lung cells, the amount of radioactivity distributed in the DNA extracted from H358 cell pellets was less than the other two (data not shown). In the present study, the B[a]P-7,8-dione-DNA adducts were only detected in A549 and HBEC-KT cells and not H358 cells, which could be accounted for by a lower formation of B [a] This is the first time that a hydrated-B[a]P-7,8-dione-N1-dGuo adduct was detected in A549 cells. Michael addition by the enol-imidazole tautomer of guanine followed by hydration could account for the formation of this hydrated-B[a]P-7,8-dione-N1-dGuo adduct. However, the specific position of guanine attack to B[a]P-7,8-dione and the specific position of B[a]P-7,8-dione hydration could not be ascertained based on mass spectrometry data only. It has been previously reported that a N1-dGuo quinone methide adduct was observed along with a N 2 -dGuo adduct and a N7-guanine adduct in duplex DNA following alkylation with quinone methides. 29, 30 It was found that the N1-dGuo adduct was preferentially formed with a quinolinyl methide in vitro and that this adduct is favored thermodynamically. In this instance, the adduct was fully characterized by 2D-NMR. 14 However, not all of the adducts detected in calf thymus DNA could be identified by comigration with authentic synthetic standards. We also reported that a B[a]P-7,8-dione-adenine adduct detected in the media of human lung cells following B[a]P-7,8-dione treatment was derived from the cellular nucleotide pool rather than DNA. 21 We find that none of the stable B[a]P-7,8-dione-DNA adducts detected in A549 and HBEC-KT cells correspond to those previously identified. These cellular B[a]P-7,8-dione-DNA adducts were different from those formed with either deoxyribonucleoside or salmon testis DNA.
Previously, B[a]P-7,8-dione was only found to be mutagenic in a yeast based system that reported p53 mutations when redox-cycling conditions were used. 32 In those experiments, reaction of B[a]P-7,8-dione with p53 cDNA in vitro failed to form adducts that were mutagenic, and subsequent work focused on oxidative DNA lesions and their ability to cause mutation. 32 It is likely that any covalent adducts that formed in these experiments would be similar to those observed in salmon testis DNA and differ from those formed in mammalian cells. This would suggest that it will be critical to obtain complete structural information on the cell based adducts so that their ability to cause mutations can be assessed.
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